This is a preview of subscription content, log in via an institution to check access.
Notes
insulin detemir, insulin glargine or insulin suspension isophane (NPH)
Swedish krona
Reference
Gundgaard J, et al. Cost-effectiveness of switching to insulin degludec from other basal insulins: evidence from Swedish real-world data. 52nd Annual Meeting of the European Association for the Study of Diabetes : (plus oral presentation) abstr. 11, 12 Sep 2016. Available from: URL: http://www.easdvirtualmeeting.org//resources/cost-effectiveness-of-switching-to-insulin-degludec-from-other-basal-insulins-evidence-from-swedish-real-world-data.
Rights and permissions
About this article
Cite this article
Switching to insulin degludec cost saving in Sweden. PharmacoEcon Outcomes News 763, 31 (2016). https://doi.org/10.1007/s40274-016-3444-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-016-3444-z